Status:
ACTIVE_NOT_RECRUITING
Biobank For MS And Other Demyelinating Diseases
Lead Sponsor:
Accelerated Cure Project for Multiple Sclerosis
Conditions:
Multiple Sclerosis
Transverse Myelitis
Eligibility:
All Genders
Brief Summary
To establish a large, longitudinal collection of high quality samples and data from subjects with MS, selected other demyelinating diseases (Transverse Myelitis (TM), Neuromyelitis Optica (NMO) or Dev...
Eligibility Criteria
Inclusion
- age 18+ able to give informed consent or individuals younger than 18 with parental permission and able to give assent
- willing to provide up to 110 ml (50 ml for \< 18 years old) of blood via venipuncture
- experienced at least one CNS demyelinating event characteristic of MS, TM, NMO, ADEM, or ON
Exclusion
- history of blood borne pathogens
- allogeneic bone marrow transplant
- clinical or radiological evidence of stroke, meningitis, or other well characterized diseases of the nervous system (with the exception of MS, TM, NMO, ADEM, or ON).
- weight less than 37 pounds
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2036
Estimated Enrollment :
3226 Patients enrolled
Trial Details
Trial ID
NCT00445367
Start Date
May 1 2006
End Date
October 1 2036
Last Update
October 2 2025
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Barrow Neurological Institute
Phoenix, Arizona, United States, 85013
2
Stanford University
Stanford, California, United States, 94305
3
The Rocky Mountain MS Center at Anschutz Medical Campus at UC Denver
Aurora, Colorado, United States, 80045
4
Shepherd Center
Atlanta, Georgia, United States, 30309